Jaundice risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 11: | Line 11: | ||
Risk factors for unconjugated hyperbilirubenemia includes:<ref name="pmid20808649">{{cite journal| author=Arora V, Kulkarni RK, Cherian S, Pillai R, Shivali M| title=Hyperbilirubinemia in normal healthy donors. | journal=Asian J Transfus Sci | year= 2009 | volume= 3 | issue= 2 | pages= 70-2 | pmid=20808649 | doi=10.4103/0973-6247.53875 | pmc=2920475 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20808649 }}</ref><ref name="pmid14013759">{{cite journal| author=ARIAS IM| title=Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults. | journal=J Clin Invest | year= 1962 | volume= 41 | issue= | pages= 2233-45 | pmid=14013759 | doi=10.1172/JCI104682 | pmc=291158 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14013759 }}</ref> | Risk factors for unconjugated hyperbilirubenemia includes:<ref name="pmid20808649">{{cite journal| author=Arora V, Kulkarni RK, Cherian S, Pillai R, Shivali M| title=Hyperbilirubinemia in normal healthy donors. | journal=Asian J Transfus Sci | year= 2009 | volume= 3 | issue= 2 | pages= 70-2 | pmid=20808649 | doi=10.4103/0973-6247.53875 | pmc=2920475 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20808649 }}</ref><ref name="pmid14013759">{{cite journal| author=ARIAS IM| title=Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults. | journal=J Clin Invest | year= 1962 | volume= 41 | issue= | pages= 2233-45 | pmid=14013759 | doi=10.1172/JCI104682 | pmc=291158 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14013759 }}</ref> | ||
==== Common Risk Factors ==== | |||
*[[Neonates]] | |||
* | |||
*Drugs - [[Rifampin]], [[Probenecid]] | *Drugs - [[Rifampin]], [[Probenecid]] | ||
*[[Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome types I and II]]<ref name="pmid12198827">{{cite journal| author=Drenth JP, Peters WH, Jansen JB| title=[From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II]. | journal=Ned Tijdschr Geneeskd | year= 2002 | volume= 146 | issue= 32 | pages= 1488-90 | pmid=12198827 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12198827 }}</ref> | *[[Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome types I and II]]<ref name="pmid12198827">{{cite journal| author=Drenth JP, Peters WH, Jansen JB| title=[From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II]. | journal=Ned Tijdschr Geneeskd | year= 2002 | volume= 146 | issue= 32 | pages= 1488-90 | pmid=12198827 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12198827 }}</ref> | ||
| Line 19: | Line 19: | ||
*[[Ethinylestradiol|Ethinyl estradiol]] | *[[Ethinylestradiol|Ethinyl estradiol]] | ||
*Liver diseases - [[chronic hepatitis]], advanced [[cirrhosis]] | *Liver diseases - [[chronic hepatitis]], advanced [[cirrhosis]] | ||
*Portosystemic shunts | |||
==== Less Common ==== | ==== Less Common Risk Factors==== | ||
*[[Dyserythropoiesis]] | *[[Dyserythropoiesis]] | ||
*Some patients with [[Gilbert's syndrome|Gilbert syndrome]] | *Some patients with [[Gilbert's syndrome|Gilbert syndrome]] | ||
*[[Drugs]] - Flavaspadic acid, Bunamiodyl | *[[Drugs]] - Flavaspadic acid, Bunamiodyl | ||
*[[Hyperthyroidism]] | *[[Hyperthyroidism]] | ||
*[[Heart failure]] | *[[Heart failure]] | ||
| Line 32: | Line 32: | ||
Risk factors for conjugated hyperbilirubinemia include: | Risk factors for conjugated hyperbilirubinemia include: | ||
==== Common | ==== Common Risk Factors ==== | ||
*[[Viral hepatitis]] | |||
*[[Alcohol]] | |||
*[[Non-alcoholic fatty liver disease]] | |||
*[[Chronic hepatitis]] | |||
*[[Primary biliary cirrhosis]] | |||
*[[Drugs]] and [[Toxin|toxins]] (eg, alkylated [[Steroid|steroids]], [[chlorpromazine]], herbal medications [eg, Jamaican bush tea], [[arsenic]]) | |||
*[[Sepsis]] and hypoperfusion states | |||
*Infiltrative diseases (eg, [[amyloidosis]], [[lymphoma]], [[sarcoidosis]], [[tuberculosis]]) | |||
*[[Pregnancy]] | |||
*[[Cirrhosis]] | |||
*[[Choledocholithiasis]] | |||
*Intrinsic and extrinsic tumors (eg, [[cholangiocarcinoma]]) | |||
*[[Primary sclerosing cholangitis]] | |||
*[[Acute pancreatitis|Acute]] and [[chronic pancreatitis]] | |||
==== Less Common Risk Factors ==== | |||
*[[Total parenteral nutrition]] | |||
*Postoperative [[cholestasis]] | |||
*Following [[Organ transplant|organ transplantation]] | |||
*Hepatic crisis in [[Sickle-cell disease|sickle-cell disease]] | |||
*[[HIV AIDS|AIDS]] | |||
*Certain [[parasitic infections]] (eg, [[Ascaris lumbricoides]], [[Opisthorchis felineus|liver flukes]]) | |||
*[[Strictures]] after invasive procedures | |||
*[[Dubin-Johnson syndrome]] | |||
*[[Rotor syndrome]] | |||
==References== | ==References== | ||
Revision as of 16:50, 6 February 2018
|
Jaundice Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Jaundice risk factors On the Web |
|
American Roentgen Ray Society Images of Jaundice risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Risk Factors
Risk factors for jaundice are classified under conjugated and unconjugated hyperbilirubinemia:[1]
Unconjugated hyperbilirubinemia
Risk factors for unconjugated hyperbilirubenemia includes:[2][3]
Common Risk Factors
- Neonates
- Drugs - Rifampin, Probenecid
- Crigler-Najjar syndrome types I and II[4]
- Gilbert syndrome
- Ethinyl estradiol
- Liver diseases - chronic hepatitis, advanced cirrhosis
- Portosystemic shunts
Less Common Risk Factors
- Dyserythropoiesis
- Some patients with Gilbert syndrome
- Drugs - Flavaspadic acid, Bunamiodyl
- Hyperthyroidism
- Heart failure
Conjugated hyperbilirubinemia
Risk factors for conjugated hyperbilirubinemia include:
Common Risk Factors
- Viral hepatitis
- Alcohol
- Non-alcoholic fatty liver disease
- Chronic hepatitis
- Primary biliary cirrhosis
- Drugs and toxins (eg, alkylated steroids, chlorpromazine, herbal medications [eg, Jamaican bush tea], arsenic)
- Sepsis and hypoperfusion states
- Infiltrative diseases (eg, amyloidosis, lymphoma, sarcoidosis, tuberculosis)
- Pregnancy
- Cirrhosis
- Choledocholithiasis
- Intrinsic and extrinsic tumors (eg, cholangiocarcinoma)
- Primary sclerosing cholangitis
- Acute and chronic pancreatitis
Less Common Risk Factors
- Total parenteral nutrition
- Postoperative cholestasis
- Following organ transplantation
- Hepatic crisis in sickle-cell disease
- AIDS
- Certain parasitic infections (eg, Ascaris lumbricoides, liver flukes)
- Strictures after invasive procedures
- Dubin-Johnson syndrome
- Rotor syndrome
References
- ↑ VanWagner LB, Green RM (2015). "Evaluating elevated bilirubin levels in asymptomatic adults". JAMA. 313 (5): 516–7. doi:10.1001/jama.2014.12835. PMC 4424929. PMID 25647209.
- ↑ Arora V, Kulkarni RK, Cherian S, Pillai R, Shivali M (2009). "Hyperbilirubinemia in normal healthy donors". Asian J Transfus Sci. 3 (2): 70–2. doi:10.4103/0973-6247.53875. PMC 2920475. PMID 20808649.
- ↑ ARIAS IM (1962). "Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults". J Clin Invest. 41: 2233–45. doi:10.1172/JCI104682. PMC 291158. PMID 14013759.
- ↑ Drenth JP, Peters WH, Jansen JB (2002). "[From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II]". Ned Tijdschr Geneeskd. 146 (32): 1488–90. PMID 12198827.